Genetic Makeup Influences Susceptibility to Severe Sepsis
In the June Anesthesiology researchers take aim at identifying genetic risk factors for sepsis a leading cause of death for critically ill patients.
Read MoreSearch Results for: infectious diseases
News Story #15790
FDA Grants Quest Diagnostics Simplexa 2009 H1N1 Test 501(k) Clearance Quest Diagnostics Inc has announced that the FDA has issued 510(k) clearance to the Simplexa™ Influenza A H1N1 (2009) test on the 3M™ integrated cycler. The Simplexa test,
Read More
Mass Spectrometry: An Emerging Path for Clinical Diagnostics
As diagnostics come to depend on increasingly sophisticated knowledge of biomarkers, mass spec emerges as a tool with revolutionary potential.
Read MoreFDA Grants Quest Diagnostics Simplexa 2009 H1N1 Test 501(k) Clearance
Quest Diagnostics Inc has announced that the FDA has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M integrated cycler.
Read MoreBio-Rad Launches MMRV IgG Kit for BioPlex 2200 System
Bio-Rad Laboratories announced the launch of the BioPlex 2200 MMRV IgG kit for use on the company’s BioPlex 2200 system. The MMRV IgG kit provides simultaneous results for the four tests that are commonly ordered together to determine a patient’s susceptibility to MMRV.
Read More